585 related articles for article (PubMed ID: 21061942)
1. Effective diagnostic tests and anthelmintic treatment for Strongyloides stercoralis make community control feasible.
Shield JM; Page W
P N G Med J; 2008; 51(3-4):105-19. PubMed ID: 21061942
[TBL] [Abstract][Full Text] [Related]
2. Strongyloidiasis--the most neglected of the neglected tropical diseases?
Olsen A; van Lieshout L; Marti H; Polderman T; Polman K; Steinmann P; Stothard R; Thybo S; Verweij JJ; Magnussen P
Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):967-72. PubMed ID: 19328508
[TBL] [Abstract][Full Text] [Related]
3. [An overview of Strongyloides stercoralis and its infections].
Ardiç N
Mikrobiyol Bul; 2009 Jan; 43(1):169-77. PubMed ID: 19334396
[TBL] [Abstract][Full Text] [Related]
4. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
[TBL] [Abstract][Full Text] [Related]
5. Association of a sex-related difference of Strongyloides stercoralis-specific IgG4 antibody titer with the efficacy of treatment of strongyloidiasis.
Satoh M; Toma H; Kiyuna S; Shiroma Y; Kokaze A; Sato Y
Am J Trop Med Hyg; 2004 Jul; 71(1):107-11. PubMed ID: 15238698
[TBL] [Abstract][Full Text] [Related]
6. Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis.
Karunajeewa H; Kelly H; Leslie D; Leydon J; Saykao P; Biggs BA
J Travel Med; 2006; 13(2):84-91. PubMed ID: 16553594
[TBL] [Abstract][Full Text] [Related]
7. Strongyloidiasis: a review of the evidence for Australian practitioners.
Johnston FH; Morris PS; Speare R; McCarthy J; Currie B; Ewald D; Page W; Dempsey K
Aust J Rural Health; 2005 Aug; 13(4):247-54. PubMed ID: 16048468
[TBL] [Abstract][Full Text] [Related]
8. Strongyloidiasis in the Northern Territory. Under-recognised and under-treated?
Fisher D; McCarry F; Currie B
Med J Aust; 1993 Jul; 159(2):88-90. PubMed ID: 8336608
[TBL] [Abstract][Full Text] [Related]
9. Parasitological and serological diagnosis of Strongyloides stercoralis in domesticated dogs from southeastern Brazil.
Júnior AF; Gonçalves-Pires MR; Silva DA; Gonçalves AL; Costa-Cruz JM
Vet Parasitol; 2006 Mar; 136(2):137-45. PubMed ID: 16321470
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Strongyloides stercoralis infection.
Siddiqui AA; Berk SL
Clin Infect Dis; 2001 Oct; 33(7):1040-7. PubMed ID: 11528578
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of ivermectin in the treatment of children parasitized by Strongyloides stercoralis].
Ordóñez LE; Angulo ES
Biomedica; 2004 Mar; 24(1):33-41. PubMed ID: 15239599
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of strongyloidiasis in kennel dogs and keepers by parasitological and serological assays.
Gonçalves AL; Machado GA; Gonçalves-Pires MR; Ferreira-Júnior A; Silva DA; Costa-Cruz JM
Vet Parasitol; 2007 Jun; 147(1-2):132-9. PubMed ID: 17448603
[TBL] [Abstract][Full Text] [Related]
13. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.
Einsiedel L; Fernandes L
Intern Med J; 2008 Sep; 38(9):697-703. PubMed ID: 19143887
[TBL] [Abstract][Full Text] [Related]
14. Human infection with Strongyloides stercoralis and other related Strongyloides species.
Nutman TB
Parasitology; 2017 Mar; 144(3):263-273. PubMed ID: 27181117
[TBL] [Abstract][Full Text] [Related]
15. Parasitological and immunological diagnosis of Strongyloides stercoralis in patients with gastrointestinal cancer.
Machado ER; Teixeira EM; Gonçalves-Pires Mdo R; Loureiro ZM; Araújo RA; Costa-Cruz JM
Scand J Infect Dis; 2008; 40(2):154-8. PubMed ID: 17852953
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.
Pacanowski J; Santos MD; Roux A; LE Maignan C; Guillot J; Lavarde V; Cornet M
Am J Trop Med Hyg; 2005 Jul; 73(1):122-4. PubMed ID: 16014846
[TBL] [Abstract][Full Text] [Related]
17. Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012.
Valerio L; Roure S; Fernández-Rivas G; Basile L; Martínez-Cuevas O; Ballesteros ÁL; Ramos X; Sabrià M;
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):465-70. PubMed ID: 23783760
[TBL] [Abstract][Full Text] [Related]
18. Screening of Strongyloides stercoralis infection in high-risk patients in Khuzestan Province, Southwestern Iran.
Ashiri A; Rafiei A; Beiromvand M; Khanzadeh A; Alghasi A
Parasit Vectors; 2021 Jan; 14(1):37. PubMed ID: 33422116
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
20. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G
Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
